The preoperative effects of oral oxypertine have been compared with those of papaveretum and atropine in 185 patients in a double-blind between-patient study. Oxypertine 20 mg given orally as a nocturnal sedative and again on the morning of operation produced relief of anxiety comparable to that of papaveretum 10 mg and atropine 0.6 mg. It is concluded that oxypertine may be of value in medication before anaesthesia.
Oxypertine is a psychotropic drug belonging to the series of indole phenylpiperazine derivatives, first described by Archer and colleagues (1962) . Its structural formula is shown in figure 1. A tranqillizing effect, similar to that of chlorpromazine, results from its central sympatholytic action by a selective decrease in the concentrations of adrenaline and noradrenaline in the brain (Penn, 1972) . Various studies have shown that oxypertine has anxiolytic and tranquillizing effects (Tyson, 1970; General Practitioner Trials, 1971) and it has been compared with the benzodiazepines in the treatment of anxiety (Bonn, Salkind and Rees, 1971) , and as a preanaesthetic medication (Norris and Wallace, 1973) . 
METHOD
We have compared the sedative effects of two regimes of preanaesthetic medication. One group of patients received papaveretum 10 mg and atropine 0.6 mg i.m., and another group received two doses of oxypertine 20 mg given orally, one on the evening before operation and one on the morning of surgery. Each patient was visited on the evening before operation and, if found suitable for inclusion in the study, the resting heart rate and arterial pressure were recorded. The patient received either the drug usually given for nocturnal sedation or oxypertine 20 mg, according to a predetermined random code. On the morning of operation, the patients received either papaveretum 10 mg and atropine 0.6 mg, given i.m., or oral oxypertine 20 mg given approximately 1 h before surgery. On arrival in the anaesthetic room, further measurements of heart rate and arterial pressure were made before the induction of anaesthesia, and the patient's mental state was graded as apprehensive, fully awake, or drowsy.
RESULTS
Results from 185 patients have been analysed, 90 in the oxypertine group, and 95 in the papaveretum/ atropine group.
Population characteristics (table I)
The mean age in the oxypertine group was 51 yr and in the papaveretum/atropine group it was 50 yr. The overall sex ratio was 1 male to 1.13 females. The initial mean heart rate, recorded on the evening before surgery, was similar for both groups and the initial systolic and diastolic arterial pressures were similar also, the mean values for both groups being 138/83 mm Hg.
The interval between preanaesthetic medication and assessment before operation ranged from 10 to 165 min, but for 82% of the patients the interval was 30-90 min; the mean interval for the oxypertine treated group was 67 min and for the papaveretum/ atropine group was 70 min.
Because of variation in the interval between premedication and assessment before operation, it was necessary to consider the response to treatment in two parts: patients with an interval of less than 60 min and those in whom the interval was greater than 60 min.
Pulse rate
The oxypertine group received no atropine and so no comparison is possible between the two groups. However, if a change of 15 beat/min is regarded as the criterion of clinical significance, there was no significant change in the oxypertine-treated group.
Systolic arterial pressure {table II)
If a change in arterial pressure of 15 mm Hg is regarded as clinically significant, there was no change in either of the treatment groups for either time interval, and for neither time interval were the changes statistically significant.
Diastolic arterial pressure {table III)
There was a significant reduction in diastolic pressure for both intervals for the oxypertine group. Neither of the changes in the papaveretum/atropine group was significant.
Subjective assessment {table IV)
When the time interval between premedication and assessment was less than 60 min, most of the patients were fully awake and not apprehensive. However, when the interval exceeded 60 min, more patients in the papaveretum/atropine group were scored as "drowsy" and the majority of the patients in the oxypertine group were "fully awake".
Side-effects {table V)
In the interval between premedication and assessment, 12 patients complained of side-effects. These were all of a minor nature; the main complaint was of a "dry mouth". this type of premedication is to allay anxiety in the patient, to ease the induction of anaesthesia, to utilize the antisialogogue action of the belladonna alkaloids and to provide a degree of analgesia during surgery. This type of premedication has several major disadvantages. It is difficult to time the administration correctly, it is time-consuming for the nursing staff and, because it is given shortly before the operation, it cannot have any effect in relieving the anxiety which patients develop in the time between admission to hospital and operation. Also, it has been shown that an analgesic given before operation may augment the respiratory depression produced by the analgesic given to relieve pain after surgery (Davie, Stephen and Scott, 1971) . Premedication techniques employing orally administered psychotropic drugs have been studied more frequently in recent years. On the basis of the results of this study, it is clear that the regimen employing oral oxypertine for premedication does not present any serious disadvantages compared with conventional premedication.
The only significant objective change found was the reduction in diastolic arterial pressure in the oxypertine group, but this did not appear to be of very great clinical significance. The oral regimen, without atropine, produced fewer complaints of a dry mouth, a side-effect which many patients find unpleasant.
The principal object of premedication is to allay anxiety in the period before operation and a search for other possible benefits should not lead to a failure to achieve this prime objective. Analgesia before surgery is probably required for only a minority of patients. A conventional technique of premedication has the additional disadvantage of an i.m. injection which is disliked by the patients, and is time-consuming for the nursing staff, who, in the United Kingdom, have to comply with the provisions of the Misuse of Drugs Act.
Oxypertine has been shown to be effective in the treatment of anxiety both in general practice and in psychiatric hospitals, and from the results of this study it would appear to be a suitable, effective oral drug for preanaesthetic medication.
PREMEDICATION ORALE AVEC L'OXYPERTINE

RESUME
Les effets pre-operatoires de l'oxypertine administree oralement ont ete compares a ceux du papaveretum et de l'atropine sur 185 patients au cours d'une etude a double inconnue entre patients. On a administre oralement 20 mg d'oxypertine comme sedatif nocturne et on a procede de meme le matin de l'operation, ce qui a produit un soulagement de l'anxiete comparable a celui obtenu avec 10 mg de papaveretum et de 0,6 mg d'atropine. On en conclut que l'oxypertine peut etre valable dans les medications administrees avant l'anesthesie. 
SUMARIO
Los efectos preoperatorios de la oxipertina por via oral han sido comparados con los del papaveretum y atropina, mediante un estudio a doble ciego con 185 pacientes, tipo comparativo entre pacientes. La oxipertina, 20 mg oralmente administrados como sedante nocturno y otra vez en la manana de la intervencion quiriirgica, produjeron un alivio de la ansiedad comparable al del papaverum 10 mg y atropina 0,6 mg. Se concluye que la oxipertina pudiera ser util en la medication anterior a la anestesia.
